Turning science into business: An optimised alternative to antibodies
Drug Discovery World
APRIL 3, 2023
As life science operates globally, the vision for the business was always to bring aptamers as an antibody alternative to researchers worldwide. This ensures that gene therapy payloads can be targeted to the desired tissue and internalised into the target cell to deliver functional payloads.
Let's personalize your content